5T4 Oncofoetal Glycoprotein: An Old Target for a Novel Prostate Cancer Immunotherapy

Oncotarget - United States
doi 10.18632/oncotarget.17666
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Characterization of the Murine 5T4 Oncofoetal Antigen: A Target for Immunotherapy in Cancer

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2002English

Cross-Presentation of the Oncofoetal Tumor Antigen 5T4 From Irradiated Prostate Cancer Cells - A Key Role for Hsp70

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Androgen Receptors Beyond Prostate Cancer: An Old Marker as a New Target

Oncotarget
Oncology
2014English

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2016English

Vaccine Immunotherapy for Prostate Cancer

2012English

Monoamine Oxidase A: A Novel Target for Progression and Metastasis of Prostate Cancer

2014English

Immunotherapy in Prostate Cancer

The Bulletin of Urooncology
2019English

Metformin and Prostate Cancer: A New Role for an Old Drug

Current Urology Reports
MedicineUrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy